Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KANELA study of hepatic safety of antiretroviral therapy in HIV/HCV coinfection
2007-004519-67Phase 4Terminated
- Sponsor
- Fight AIDS and Infectious Diseases Foundation
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nevirapine and lopinavir + ritonavir in human immunodeficiency virus infection (HIV) and hepatitis C virus infection (2 arms), sponsored by Fight AIDS and Infectious Diseases Foundation. Started Dec 2007; status: terminated.
02
Drugs
nevirapinelopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)hepatitis C virus infection
Beyond the preview
Go deeper on 2007-004519-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004519-67.